MicroRNA-10a targets CHL1 and promotes cell growth, migration and invasion in human cervical cancer cells

Cancer Letters

Volumn 324, Issue 2, 2012, Pages 186-196

  Long, Mei Jing ^a   Wu, Fu Xia ^a   Li, Pu ^b   Liu, Min ^a   Li, Xin ^a   Tang, Hua ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b Tianjin Central Hospital of Gynecology Obstetrics   (China)

Author keywords

Cervical cancer; CHL1; Invasion; MicroRNA 10a; Migration

Indexed keywords

CLOSE HOMOLOG OF L1; MEMBRANE PROTEIN; MICRORNA; MICRORNA 10A; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INVASION; CELL INVASION; CELL MIGRATION; CLOSE HOMOLOG OF L1 GENE; COLONY FORMATION; CONTROLLED STUDY; FEMALE; GENE; GENE FUNCTION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; RNA ANALYSIS; UPREGULATION; UTERINE CERVIX CANCER;

3' UNTRANSLATED REGIONS; BINDING SITES; CELL ADHESION MOLECULES; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; RNA INTERFERENCE; TIME FACTORS; TRANSFECTION; UTERINE CERVICAL NEOPLASMS;

EID: 84864384329     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2012.05.022     Document Type: Article

References (55)

1. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
2. Pillai R.S. MicroRNA function: multiple mechanisms for a tiny RNA?. RNA 2005, 11:1753-1761.
3. Lynam-Lennon N., Maher S.G., Reynolds J.V. The roles of microRNA in cancer and apoptosis. Biol. Rev. Camb. Philos. Soc. 2009, 84:55-71.
4. Urbich C., Kuehbacher A., Dimmeler S. Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc. Res. 2008, 79:581-588.
5. Bueno M.J., Perez de Castro I., Malumbres M. Control of cell proliferation pathways by microRNAs. Cell Cycle 2008, 7:3143-3148.
6. Schickel R., Boyerinas B., Park S.M., Peter M.E. MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene 2008, 27:5959-5974.
7. Imam J.S., Buddavarapu K., Lee-Chang J.S., Ganapathy S., Camosy C., Chen Y., Rao M.K. MicroRNA-185 suppresses tumor growth and progression by targeting the Six1 oncogene in human cancers. Oncogene 2010, 29:4971-4979.
8. Greenberg E., Hershkovitz L., Itzhaki O., Hajdu S., Nemlich Y., Ortenberg R., Gefen N., Edry L., Modai S., Keisari Y., Besser M.J., Schachter J., Shomron N., Markel G. Regulation of cancer aggressive features in melanoma cells by microRNAs. PLoS One 2011, 6:e18936.
9. Suzuki H.I., Yamagata K., Sugimoto K., Iwamoto T., Kato S., Miyazono K. Modulation of microRNA processing by p53. Nature 2009, 460:529-533.
10. Albulescu R., Neagu M., Albulescu L., Tanase C. Tissular and soluble miRNAs for diagnostic and therapy improvement in digestive tract cancers. Exp. Rev. Mol. Diagn. 2011, 11:101-120.
11. Cho W.C. MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Int. J. Biochem. Cell Biol. 2010, 42:1273-1281.
12. Wang F., Li Y., Zhou J., Xu J., Peng C., Ye F., Shen Y., Lu W., Wan X., Xie X. MiR-375 is down-regulated in squamous cervical cancer and inhibits cell migration and invasion via targeting transcription factor SP1. Am. J. Pathol. 2011, 179:2580-2588.
13. Cho W.C. MicroRNAs in cancer - from research to therapy. Biochim. Biophys. Acta 1805, 2010:209-217.
14. Li Z., Cao Y., Jie Z., Liu Y., Li Y., Li J., Zhu G., Liu Z., Tu Y., Peng G., Lee D.W., Park S.S. MiR-495 and miR-551a inhibit the migration and invasion of human gastric cancer cells by directly interacting with PRL-3. Cancer Lett. 2012, 10.1016/j.canlet.2012.03.029.
15. Xu J., Li Y., Wang F., Wang X., Cheng B., Ye F., Xie X., Zhou C., Lu W. Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer. Oncogene 2012, 10.1038/onc.2012.121.
16. Shi M., Liu D., Duan H., Shen B., Guo N. Metastasis-related miRNAs, active players in breast cancer invasion, and metastasis. Cancer Metastasis Rev. 2010, 29:785-799.
17. Gaziel-Sovran A., Segura M.F., Di Micco R., Collins M.K., Hanniford D., Vega-Saenz de Miera E., Rakus J.F., Dankert J.F., Shang S., Kerbel R.S., Bhardwaj N., Shao Y., Darvishian F., Zavadil J., Erlebacher A., Mahal L.K., Osman I., Hernando E. MiR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis. Cancer Cell 2011, 20:104-118.
18. Liu H., Focia P.J., He X. Homophilic adhesion mechanism of neurofascin, a member of the L1 family of neural cell adhesion molecules. J. Biol. Chem. 2011, 286:797-805.
19. Li Y., Galileo D.S. Soluble L1CAM promotes breast cancer cell adhesion and migration in vitro, but not invasion. Cancer Cell Int. 2010, 10:34.
20. Gavert N., Vivanti A., Hazin J., Brabletz T., Ben-Ze'ev A. L1-mediated colon cancer cell metastasis does not require changes in EMT and cancer stem cell markers. Mol. Cancer Res. 2010, 9:14-24.
21. Raveh S., Gavert N., Ben-Ze'ev A. L1 cell adhesion molecule (L1CAM) in invasive tumors. Cancer Lett. 2009, 282:137-145.
22. Gast D., Riedle S., Schabath H., Schlich S., Schneider A., Issa Y., Stoeck A., Fogel M., Joumaa S., Wenger T., Herr I., Gutwein P., Altevogt P. L1 augments cell migration and tumor growth but not beta3 integrin expression in ovarian carcinomas. Int. J. Cancer 2005, 115:658-665.
23. Tischler V., Pfeifer M., Hausladen S., Schirmer U., Bonde A.K., Kristiansen G., Sos M.L., Weder W., Moch H., Altevogt P., Soltermann A. L1CAM protein expression is associated with poor prognosis in non-small cell lung cancer. Mol. Cancer 2011, 10:127.
24. Tsutsumi S., Morohashi S., Kudo Y., Akasaka H., Ogasawara H., Ono M., Takasugi K., Ishido K., Hakamada K., Kijima H. L1 Cell adhesion molecule (L1CAM) expression at the cancer invasive front is a novel prognostic marker of pancreatic ductal adenocarcinoma. J. Surg. Oncol. 2011, 103:669-673.
25. Jung J., Son Y.S., Park H., Jeon S.K., Lee J.W., Choi S.Y., Kim J.M., Kwon Y.G., Hong H.J., Min J.K. The cell adhesion molecule L1 promotes gallbladder carcinoma progression in vitro and in vivo. Oncol. Rep. 2011, 25:945-952.
26. Senchenko V.N., Krasnov G.S., Dmitriev A.A., Kudryavtseva A.V., Anedchenko E.A., Braga E.A., Pronina I.V., Kondratieva T.T., Ivanov S.V., Zabarovsky E.R., Lerman M.I. Differential expression of CHL1 gene during development of major human cancers. PLoS One 2011, 6:e15612.
27. Kang H.W., Wang F., Wei Q., Zhao Y.F., Liu M., Li X., Tang H. MiR-20a promotes migration and invasion by regulating TNKS2 in human cervical cancer cells. FEBS Lett. 2012, 586:897-904.
28. Xu X.M., Wang X.B., Chen M.M., Liu T., Li Y.X., Jia W.H., Liu M., Li X., Tang H. MicroRNA-19a and -19b regulate cervical carcinoma cell proliferation and invasion by targeting CUL5. Cancer Lett. 2012, 10.1016/j.canlet.2012.02.038.
29. Qiang R., Wang F., Shi L.Y., Liu M., Chen S., Wan H.Y., Li Y.X., Li X., Gao S.Y., Sun B.C., Tang H. Plexin-B1 is a target of miR-214 in cervical cancer and promotes the growth and invasion of HeLa cells. Int. J. Biochem. Cell Biol. 2011, 43:632-641.
30. Yang Z., Chen S., Luan X., Li Y., Liu M., Li X., Liu T., Tang H. MicroRNA-214 is aberrantly expressed in cervical cancers and inhibits the growth of HeLa cells. IUBMB Life 2009, 61:1075-1082.
31. Peng R.Q., Wan H.Y., Li H.F., Liu M., Li X., Tang H. MicroRNA-214 suppresses growth and invasiveness of cervical cancer cells by targeting UDP-N-acetyl-alpha-D-galactosamine:Polypeptide N-Acetylgalactosaminyltransferase 7. J. Biol. Chem. 2012, 287:14301-14309.
32. Tian R.Q., Wang X.H., Hou L.J., Jia W.H., Yang Q., Li Y.X., Liu M., Li X., Tang H. MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis. J. Biol. Chem. 2011, 286:25556-25563.
33. Liu T., Tang H., Lang Y., Liu M., Li X. MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin. Cancer Lett. 2009, 273:233-242.
34. Griffiths-Jones S., Grocock R.J., van Dongen S., Bateman A., Enright A.J. MiRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 2006, 34:D140-144.
35. Schmittgen T.D., Lee E.J., Jiang J., Sarkar A., Yang L., Elton T.S., Chen C. Real-time PCR quantification of precursor and mature microRNA. Methods 2008, 44:31-38.
36. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
37. Wilmott J.S., Zhang X.D., Hersey P., Scolyer R.A. The emerging important role of microRNAs in the pathogenesis, diagnosis and treatment of human cancers. Pathology 2011, 43:657-671.
38. Gandellini P., Profumo V., Folini M., Zaffaroni N. MicroRNAs as new therapeutic targets and tools in cancer. Exp. Opin. Ther. Targets 2011, 15:265-279.
39. Martello G., Rosato A., Ferrari F., Manfrin A., Cordenonsi M., Dupont S., Enzo E., Guzzardo V., Rondina M., Spruce T., Parenti A.R., Daidone M.G., Bicciato S., Piccolo S. A MicroRNA targeting dicer for metastasis control. Cell 2010, 141:1195-1207.
40. Baranwal S., Alahari S.K. MiRNA control of tumor cell invasion and metastasis. Int. J. Cancer 2010, 126:1283-1290.
41. Zhang L., Huang J., Yang N., Greshock J., Megraw M.S., Giannakakis A., Liang S., Naylor T.L., Barchetti A., Ward M.R., Yao G., Medina A., O'Brien-Jenkins A., Katsaros D., Hatzigeorgiou A., Gimotty P.A., Weber B.L., Coukos G. MicroRNAs exhibit high frequency genomic alterations in human cancer. Proc. Natl. Acad. Sci. USA 2006, 103:9136-9141.
42. Varnholt H., Drebber U., Schulze F., Wedemeyer I., Schirmacher P., Dienes H.P., Odenthal M. MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma. Hepatology 2008, 47:1223-1232.
43. Volinia S., Calin G.A., Liu C.G., Ambs S., Cimmino A., Petrocca F., Visone R., Iorio M., Roldo C., Ferracin M., Prueitt R.L., Yanaihara N., Lanza G., Scarpa A., Vecchione A., Negrini M., Harris C.C., Croce C.M. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. USA 2006, 103:2257-2261.
44. Ma L., Teruya-Feldstein J., Weinberg R.A. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007, 449:682-688.
45. Weiss F.U., Marques I.J., Woltering J.M., Vlecken D.H., Aghdassi A., Partecke L.I., Heidecke C.D., Lerch M.M., Bagowski C.P. Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer. Gastroenterology 2009, 137:2136-2145. e2131-2137.
46. Demyanenko G.P., Halberstadt A.I., Rao R.S., Maness P.F. CHL1 cooperates with PAK1-3 to regulate morphological differentiation of embryonic cortical neurons. Neuroscience 2010, 165:107-115.
47. Ango F., Wu C., Van der Want J.J., Wu P., Schachner M., Huang Z.J. Bergmann glia and the recognition molecule CHL1 organize GABAergic axons and direct innervation of Purkinje cell dendrites. PLoS Biol. 2008, 6:e103.
48. Ross D.T., Scherf U., Eisen M.B., Perou C.M., Rees C., Spellman P., Iyer V., Jeffrey S.S., Van de Rijn M., Waltham M., Pergamenschikov A., Lee J.C., Lashkari D., Shalon D., Myers T.G., Weinstein J.N., Botstein D., Brown P.O. Systematic variation in gene expression patterns in human cancer cell lines. Nat. Genet. 2000, 24:227-235.
49. Wei M.H., Karavanova I., Ivanov S.V., Popescu N.C., Keck C.L., Pack S., Eisen J.A., Lerman M.I. In silico-initiated cloning and molecular characterization of a novel human member of the L1 gene family of neural cell adhesion molecules. Hum. Genet. 1998, 103:355-364.
50. Huang X., Zhu L.L., Zhao T., Wu L.Y., Wu K.W., Schachner M., Xiao Z.C., Fan M. CHL1 negatively regulates the proliferation and neuronal differentiation of neural progenitor cells through activation of the ERK1/2 MAPK pathway. Mol. Cell Neurosci. 2011, 46:296-307.
51. Whale A., Hashim F.N., Fram S., Jones G.E., Wells C.M. Signalling to cancer cell invasion through PAK family kinases. Front Biosci. 2011, 16:849-864.
52. Eswaran J., Soundararajan M., Knapp S. Targeting group II PAKs in cancer and metastasis. Cancer Metastasis Rev. 2009, 28:209-217.
53. Tam G.W., van de Lagemaat L.N., Redon R., Strathdee K.E., Croning M.D., Malloy M.P., Muir W.J., Pickard B.S., Deary I.J., Blackwood D.H., Carter N.P., Grant S.G. Confirmed rare copy number variants implicate novel genes in schizophrenia. Biochem. Soc. Trans. 2010, 38:445-451.
54. Yang W., Lee D.Y., Ben-David Y. The roles of microRNAs in tumorigenesis and angiogenesis. Int. J. Physiol. Pathophysiol. Pharmacol. 2011, 3:140-155.
55. Sayed D., Abdellatif M. MicroRNAs in development and disease. Physiol. Rev. 2011, 91:827-887.